Trial Profile
Retrospective study of combination therapy of verteporfin photodynamic therapy and ranibizumab in patients with Polypoidal choroidal vasculopathy (PCV)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary) ; Verteporfin (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2015 New trial record